UGANDA-IMMIGRATION
20.6.2022 10:02:05 CEST | Business Wire | Press release
When it comes to Uganda, travelers will immediately remember a vast expanse of savannah across the country, a diverse ethnic culture, and a wealth of wildlife. Besides safari tours, most international travelers also visit this beautiful country to discover the diverse culture in Uganda.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220618005004/en/
The culture of Uganda and its age-old tradition attract many foreign tourists
Uganda tourism statistics show a gradual increase in the number of tourists to Uganda in 2021. Thanks to the reopening of tourism, Uganda is expected to welcome more international travelers in 2022.
The culture of Uganda is made up of more than 50 tribes, including Ugandan indigenous people, and a small population migrated from Europeans, Asians, and Arabians. There are four main ethnic groups in Uganda, including the Bantu, the Nilotics, the NiloHamitics, and the Hamites.
The importance of culture in Uganda has been recognized through the cultural values it brings to the community. In this diverse culture, the traditional dance has always been a part of Uganda's identity. Each ethnic community has distinctive dances with different meanings and purposes, making it easy for visitors to distinguish between the tribes. Local people often integrate these dances into their day-to-day life to keep and share cultural values with different generations.
The "Gomesi" and the "Kanzu" are traditional costumes in Uganda. The "Gomesi" is a national dress in Uganda that Ugandan women often wear at events or ceremonies, while "Kanzu" is worn by Ugandan men during cultural functions.
Some cultural sites for travelers to immerse in cultures and traditions in Uganda
The best way for travelers to understand the diversity of new cultures and traditions in Uganda is to interact with the local community.
Going off-the-beaten-path in Karamoja village, travelers can discover the unique culture of the local people through their dress code, traditional dances, and local crafts. Karamojong people are mainly semi-nomadic pastoralists living in the North Eastern region of Uganda for hundreds of years.
The Ndere Cultural Center is set up with the primary purpose of maintaining Uganda's culture alive. This Center is an ideal destination for travelers to understand different cultures in Uganda . They can enjoy the cultural song and dance performances with handmade instruments from various tribes in Uganda.
Before departing, travelers should consider purchasing travel insurance that will help them cover their medical expenses should things go wrong and provide them additional benefits on their cultural tours in Uganda.
Uganda Immigration Services recommends tourists to apply for Uganda e Visa online beforehand
Travelers should keep in mind that they need to get a visa to enter Uganda. The fastest and most convenient way to obtain a visa is to apply for Uganda e Visa online .
“I had difficulty applying for a Uganda e-Visa on the Government website. Fortunately, experts from Uganda Immigration Services have helped me simplify the e-Visa application process, so I can obtain an e-Visa easier at a reasonable Uganda visa fee. I was definitely impressed with their enthusiasm and professionalism.”, said Key Smith.
Experts from Uganda Immigration Services also suggest that travelers should check Uganda visa requirements so that their visa application will be processed faster without interruption.
Uganda Immigration Services provides customers the comprehensive service of e-visa, travel insurance, sim card, and car pick up. From now on, travelers can expect to get an e-visa to the Pearl of Africa easier than ever before.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220618005004/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom